Bromazepam
USP/1076465 - United States Pharmacopeia (USP) Reference Standard
Synonym: 7-
CAS Number: 1812-30-2
Empirical Formula (Hill Notation): C14H10BrN3O
Molecular Weight: 316.15
MDL Number: MFCD00057902
Linear Formula: C14H10BrN3O
Product Type: Chemical
| application(s) | pharmaceutical (small molecule) |
| drug control | regulated under CDSA - not available from Sigma-Aldrich Canada; psicótropo (Spain); Decreto Lei 15/93: Tabela IV (Portugal) |
| format | neat |
| grade | pharmaceutical primary standard |
| InChI | 1S/C14H10BrN3O/c15-9-4-5- |
| InChI key | VMIYHDSEFNYJSL-UHFFFAOYSA |
| manufacturer/tradename | USP |
| SMILES string | O=C(CN=C1C2=CC=CC=N2)NC3= |
| Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
| Application: | Bromazepam may be used as a standard in the quantitative determination of bromazepam in biosamples like human plasma using high performance liquid chromatography coupled with tandem mass spectrometry (HPLC-MS-MS). |
| General description: | Bromazepam belongs to the 1,4-benzodiazepine class of compounds. It is a type of psychotropic drug, which finds therapeutic applications as an anti-anxiety agent. |
| Other Notes: | Sales restrictions may apply. |
| Symbol |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| UNSPSC | 41116107 |